Search Results 411-420 of 12558 for alp

1. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Liver function tests: alanine aminotransferase (ALT) <2x upper limit of normal (ULN); alkaline phosphatase <=1.5xULN; bilirubin <=1.5xULN (isolated ...

2. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   ... Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within 14 days of study ...

3. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   ... Alkaline phosphatase >3 × ULN, g) Serum creatinine >2 × ULN; Antibiotic use within past 14 days; Probiotics use within past 7 days. Participating Mayo Clinic ...

4. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

   Alkaline phosphatase (AP) ≤ 2.5 x ULN; Aspartate transaminase (AST) or alanine transaminase (ALT) ≤3 x ULN, unless considered due to organ leukemic ...

5. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer - Mayo Clinic

   - Alkaline phosphatase ≤ 2.5 x ULN or alkaline phosphatase ≤ 5 x ULN if elevations are due to liver metastases. - Electrocardiogram (EKG) completed ≤ 15 ...

6. Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim 2) - Mayo Clinic

   ... alkaline phosphatase or bilirubin > 2x normal); Serum sodium of < 125 mEq/dL or > 150 mEq/dL; Serum potassium of < 3.2 mEq/dL or > 5.9 mEq/dL; Prior diagnosis ...

7. Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma - Mayo Clinic

   Alkaline phosphatase limit =< 2.5 x ULN (=< 5 x ULN for subjects with liver involvement of their cancer). Lipase =< 1.5 x the ULN. Serum creatinine =< 1.5 x ...

8. A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in Patients with Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) at Intermediate Risk of Recurrence - Mayo Clinic

   ... ALP ≤2.5 × ULN, and Estimated glomerular filtration rate (eGFR) ≥30 mL/min. Has no evidence of active urinary tract infection (UTI) at Screening and ...

9. Phase ll Study of Pirfenidone in Patients With RAILD - Mayo Clinic

   Alkaline phosphatase > 2.5 X ULN. History of end-stage renal disease requiring dialysis. History of unstable or deteriorating cardiac disease, or unstable ...

10. Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - Mayo Clinic

    Alkaline phosphatase less than or equal to 2.5 x ULN; Neuropathy (sensory or motor) less than or equal to Common Terminology Criteria for Adverse Events ...